SEARCH

SEARCH BY CITATION

References

  • Ades, L., Guerci, A., Raffoux, E., Sanz, M., Chevallier, P., Lapusan, S., Recher, C., Thomas, X., Rayon, C., Castaigne, S., Tournilhac, O., de Botton, S., Ifrah, N., Cahn, J.Y., Solary, E., Gardin, C., Fegeux, N., Bordessoule, D., Ferrant, A., Meyer-Monard, S., Vey, N., Dombret, H., Degos, L., Chevret, S. & Fenaux, P. (2010) Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience. Blood, 115, 16901696.
  • Asou, N., Adachi, K., Tamura, J., Kanamaru, A., Kageyama, S., Hiraoka, A., Omoto, E., Akiyama, H., Tsubaki, K., Saito, K., Kuriyama, K., Oh, H., Kitano, K., Miyawaki, S., Takeyama, K., Yamada, O., Nishikawa, K., Takahashi, M., Matsuda, S., Ohtake, S., Suzushima, H., Emi, N. & Ohno, R. (1998) Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group. Journal of Clinical Oncology, 16, 7885.
  • Avvisati, G., Lo-Coco, F., Paoloni, F.P., Petti, M.C., Diverio, D., Vignetti, M., Latagliata, R., Specchia, G., Baccarani, M., Di Bona, E., Fioritoni, G., Marmont, F., Rambaldi, A., Di Raimondo, F., Kropp, M.G., Pizzolo, G., Pogliani, E.M., Rossi, G., Cantore, N., Nobile, F., Gabbas, A., Ferrara, F., Fazi, P., Amadori, S. & Mandelli, F. (2011) AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance. Blood, 117, 47164725.
  • Barragan, E., Montesinos, P., Camos, M., Gonzalez, M., Calasanz, M.J., Roman-Gomez, J., Gomez-Casares, M.T., Ayala, R., Lopez, J., Fuster, O., Colomer, D., Chillon, C., Larrayoz, M.J., Sanchez-Godoy, P., Gonzalez-Campos, J., Manso, F., Amador, M.L., Vellenga, E., Lowenberg, B. & Sanz, M.A. (2011) Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy. Haematologica, 96, 14701477.
  • Beitinjaneh, A., Jang, S., Roukoz, H. & Majhail, N.S. (2010) Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations in acute promyelocytic leukemia: a systematic review. Leukemia Research, 34, 831836.
  • Damm, F., Oberacker, T., Thol, F., Surdziel, E., Wagner, K., Chaturvedi, A., Morgan, M., Bomm, K., Gohring, G., Lubbert, M., Kanz, L., Fiedler, W., Schlegelberger, B., Heil, G., Schlenk, R.F., Dohner, K., Dohner, H., Krauter, J., Ganser, A. & Heuser, M. (2011) Prognostic importance of histone methyltransferase MLL5 expression in acute myeloid leukemia. Journal of Clinical Oncology, 29, 682689.
  • De Marchis, M.L., Ballarino, M., Salvatori, B., Puzzolo, M.C., Bozzoni, I. & Fatica, A. (2009) A new molecular network comprising PU.1, interferon regulatory factor proteins and miR-342 stimulates ATRA-mediated granulocytic differentiation of acute promyelocytic leukemia cells. Leukemia, 23, 856862.
  • Emerling, B.M., Bonifas, J., Kratz, C.P., Donovan, S., Taylor, B.R., Green, E.D., Le Beau, M.M. & Shannon, K.M. (2002) MLL5, a homolog of Drosophila trithorax located within a segment of chromosome band 7q22 implicated in myeloid leukemia. Oncogene, 21, 48494854.
  • Ernst, P., Fisher, J.K., Avery, W., Wade, S., Foy, D. & Korsmeyer, S.J. (2004) Definitive hematopoiesis requires the mixed-lineage leukemia gene. Developmental Cell, 6, 437443.
  • Falini, B., Flenghi, L., Fagioli, M., Lo, C.F., Cordone, I., Diverio, D., Pasqualucci, L., Biondi, A., Riganelli, D., Orleth, A., Liso, A., Martelli, M.F., Pelicci, P.G. & Pileri, S. (1997) Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML). Blood, 90, 40464053.
  • Ferrara, F., Morabito, F., Martino, B., Specchia, G., Liso, V., Nobile, F., Boccuni, P., Di Noto, R., Pane, F., Annunziata, M., Schiavone, E.M., De, S.M., Guglielmi, C., Del Vecchio, L. & Lo Coco, F. (2000) CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy. Journal of Clinical Oncology, 18, 12951300.
  • Figueroa, M.E., Lugthart, S., Li, Y., Erpelinck-Verschueren, C., Deng, X., Christos, P.J., Schifano, E., Booth, J., van Putten, W., Skrabanek, L., Campagne, F., Mazumdar, M., Greally, J.M., Valk, P.J., Lowenberg, B., Delwel, R. & Melnick, A. (2010) DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. Cancer Cell, 17, 1327.
  • Gray, R.J. (1998) A class of K-sample tests for comparing the cumulative incidence of a competing risk. The Annals of Statistics, 16, 11401154.
  • Heuser, M., Yap, D.B., Leung, M., de Algara, T.R., Tafech, A., McKinney, S., Dixon, J., Thresher, R., Colledge, B., Carlton, M., Humphries, R.K. & Aparicio, S.A. (2009) Loss of MLL5 results in pleiotropic hematopoietic defects, reduced neutrophil immune function, and extreme sensitivity to DNA demethylation. Blood, 113, 14321443.
  • Hughes, C.M., Rozenblatt-Rosen, O., Milne, T.A., Copeland, T.D., Levine, S.S., Lee, J.C., Hayes, D.N., Shanmugam, K.S., Bhattacharjee, A., Biondi, C.A., Kay, G.F., Hayward, N.K., Hess, J.L. & Meyerson, M. (2004) Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Molecular Cell, 13, 587597.
  • Jacomo, R.H., Melo, R.A., Souto, F.R., de Mattos, E.R., de Oliveira, C.T., Fagundes, E.M., Bittencourt, H.N., Bittencourt, R.I., Bortolheiro, T.C., Paton, E.J., Bendlin, R., Ismael, S., Chauffaille, M.L., Silva, D., Pagnano, K.B., Ribeiro, R. & Rego, E.M. (2007) Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines. Haematologica, 92, 14311432.
  • Jacomo, R.H., Santana-Lemos, B.A., Lima, A.S., Assis, P.A., Lange, A.P., Figueiredo-Pontes, L.L., Oliveira, L.O., Bassi, S.C., Benicio, M.T., Baggio, M.S., Garcia, A.B., Falcao, R.P. & Rego, E.M. (2012) Methionine-induced hyperhomocysteinemia reverts fibrinolytic pathway activation in a murine model of acute promyelocytic leukemia. Blood, 120, 207213.
  • Kwaan, H.C. & Rego, E.M. (2010) Role of microparticles in the hemostatic dysfunction in acute promyelocytic leukemia. Seminars in Thrombosis and Hemostasis, 36, 917924.
  • Le Beau, M.M., Davis, E.M., Patel, B., Phan, V.T., Sohal, J. & Kogan, S.C. (2003) Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice identify cooperating events and genetic pathways to acute promyelocytic leukemia. Blood, 102, 10721074.
  • Lo-Coco, F., Avvisati, G., Vignetti, M., Thiede, C., Orlando, S.M., Iacobelli, S., Ferrara, F., Fazi, P., Cicconi, L., Di Bona, E., Specchia, G., Sica, S., Divona, M., Levis, A., Fiedler, W., Cerqui, E., Breccia, M., Fioritoni, G., Salih, H.R., Cazzola, M., Melillo, L., Carella, A.M., Brandts, C.H., Morra, E., von Lilienfeld-Toal, M., Hertenstein, B., Wattad, M., Lubbert, M., Hanel, M., Schmitz, N., Link, H., Kropp, M.G., Rambaldi, A., La Nasa, G., Luppi, M., Ciceri, F., Finizio, O., Venditti, A., Fabbiano, F., Dohner, K., Sauer, M., Ganser, A., Amadori, S., Mandelli, F., Dohner, H., Ehninger, G., Schlenk, R.F. & Platzbecker, U. (2013) Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N.Engl. Journal of Medicine, 369, 111121.
  • Madan, V., Madan, B., Brykczynska, U., Zilbermann, F., Hogeveen, K., Dohner, K., Dohner, H., Weber, O., Blum, C., Rodewald, H.R., Sassone-Corsi, P., Peters, A.H. & Fehling, H.J. (2009) Impaired function of primitive hematopoietic cells in mice lacking the Mixed-Lineage-Leukemia homolog MLL5. Blood, 113, 14441454.
  • Martens, J.H., Brinkman, A.B., Simmer, F., Francoijs, K.J., Nebbioso, A., Ferrara, F., Altucci, L. & Stunnenberg, H.G. (2010) PML-RARalpha/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia. Cancer Cell, 17, 173185.
  • Milne, T.A., Briggs, S.D., Brock, H.W., Martin, M.E., Gibbs, D., Allis, C.D. & Hess, J.L. (2002) MLL targets SET domain methyltransferase activity to Hox gene promoters. Molecular Cell, 10, 11071117.
  • Montesinos, P., Rayon, C., Vellenga, E., Brunet, S., Gonzalez, J., Gonzalez, M., Holowiecka, A., Esteve, J., Bergua, J., Gonzalez, J.D., Rivas, C., Tormo, M., Rubio, V., Bueno, J., Manso, F., Milone, G., de la Serna, J., Perez, I., Perez-Encinas, M., Krsnik, I., Ribera, J.M., Escoda, L., Lowenberg, B. & Sanz, M.A. (2011) Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens. Blood, 117, 17991805.
  • Murray, C.K., Estey, E., Paietta, E., Howard, R.S., Edenfield, W.J., Pierce, S., Mann, K.P., Bolan, C. & Byrd, J.C. (1999) CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome? Journal of Clinical Oncology, 17, 293297.
  • Nakamura, T., Mori, T., Tada, S., Krajewski, W., Rozovskaia, T., Wassell, R., Dubois, G., Mazo, A., Croce, C.M. & Canaani, E. (2002) ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Molecular Cell, 10, 11191128.
  • Noguera, N.I., Breccia, M., Divona, M., Diverio, D., Costa, V., De Santis, S., Avvisati, G., Pinazzi, M.B., Petti, M.C., Mandelli, F. & Lo Coco, F. (2002) Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol. Leukemia, 16, 21852189.
  • Rego, E.M., He, L.Z., Warrell, R.P. Jr, Wang, Z.G. & Pandolfi, P.P. (2000) Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins. Proceedings of the National Academy of Sciences of the United States of America, 97, 1017310178.
  • Rego, E.M., Kim, H.T., Ruiz-Arguelles, G.J., Undurraga, M.S., Uriarte, M.R., Jacomo, R.H., Gutierrez-Aguirre, H., Melo, R.A., Bittencourt, R., Pasquini, R., Pagnano, K., Fagundes, E.M., Chauffaille, M.L., Chiattone, C.S., Martinez, L., Meillon, L.A., Gomez-Almaguer, D., Kwaan, H.C., Garces-Eisele, J., Gallagher, R., Niemeyer, C.M., Schrier, S.L., Tallman, M., Grimwade, D., Ganser, A., Berliner, N., Ribeiro, R.C., Lo-Coco, F., Lowenberg, B. & Sanz, M.A. (2013) Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL. Blood, 121, 19351943.
  • Sanz, M.A., Lo Coco, F., Martin, G., Avvisati, G., Rayon, C., Barbui, T., Diaz-Mediavilla, J., Fioritoni, G., Gonzalez, J.D., Liso, V., Esteve, J., Ferrara, F., Bolufer, P., Bernasconi, C., Gonzalez, M., Rodeghiero, F., Colomer, D., Petti, M.C., Ribera, J.M. & Mandelli, F. (2000) Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood, 96, 12471253.
  • Sanz, M.A., Martin, G., Gonzalez, M., Leon, A., Rayon, C., Rivas, C., Colomer, D., Amutio, E., Capote, F.J., Milone, G.A., de la Serna, J., Roman, J., Barragan, E., Bergua, J., Escoda, L., Parody, R., Negri, S., Calasanz, M.J. & Bolufer, P. (2004) Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group. Blood, 103, 12371243.
  • Sanz, M.A., Montesinos, P., Rayon, C., Holowiecka, A., de la Serna, J., Milone, G., de Lisa, E., Brunet, S., Rubio, V., Ribera, J.M., Rivas, C., Krsnik, I., Bergua, J., Gonzalez, J., Diaz-Mediavilla, J., Rojas, R., Manso, F., Ossenkoppele, G., Gonzalez, J.D. & Lowenberg, B. (2010) Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome. Blood, 115, 51375146.
  • Saumet, A., Vetter, G., Bouttier, M., Portales-Casamar, E., Wasserman, W.W., Maurin, T., Mari, B., Barbry, P., Vallar, L., Friederich, E., Arar, K., Cassinat, B., Chomienne, C. & Lecellier, C.H. (2009) Transcriptional repression of microRNA genes by PML-RARA increases expression of key cancer proteins in acute promyelocytic leukemia. Blood, 113, 412421.
  • Schnittger, S., Bacher, U., Haferlach, C., Kern, W., Alpermann, T. & Haferlach, T. (2011) Clinical impact of FLT3 mutation load in acute promyelocytic leukemia with t(15;17)/PML-RARA. Haematologica, 96, 17991807.
  • de la Serna, J., Montesinos, P., Vellenga, E., Rayon, C., Parody, R., Leon, A., Esteve, J., Bergua, J.M., Milone, G., Deben, G., Rivas, C., Gonzalez, M., Tormo, M., Diaz-Mediavilla, J., Gonzalez, J.D., Negri, S., Amutio, E., Brunet, S., Lowenberg, B. & Sanz, M.A. (2008) Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin. Blood, 111, 33953402.
  • Sunter, N.J., Scott, K., Hills, R., Grimwade, D., Taylor, S., Worrillow, L.J., Fordham, S.E., Forster, V.J., Jackson, G., Bomken, S., Jones, G. & Allan, J.M. (2012) A functional variant in the core promoter of the CD95 cell death receptor gene predicts prognosis in acute promyelocytic leukemia. Blood, 119, 196205.
  • de Thé, H., Le Bras, M. & Lallemand-Breitenbach, V. (2012) The cell biology of disease: acute promyelocytic leukemia, arsenic, and PML bodies. Journal of Cell Biology, 198, 1121.
  • Wartman, L.D., Welch, J.S., Uy, G.L., Klco, J.M., Lamprecht, T., Varghese, N., Nagarajan, R. & Ley, T.J. (2012) Expression and function of PML-RARA in the hematopoietic progenitor cells of Ctsg-PML-RARA mice. PLoS One, 7, e46529.
  • Welch, J.S., Ley, T.J., Link, D.C., Miller, C.A., Larson, D.E., Koboldt, D.C., Wartman, L.D., Lamprecht, T.L., Liu, F., Xia, J., Kandoth, C., Fulton, R.S., McLellan, M.D., Dooling, D.J., Wallis, J.W., Chen, K., Harris, C.C., Schmidt, H.K., Kalicki-Veizer, J.M., Lu, C., Zhang, Q., Lin, L., O'Laughlin, M.D., McMichael, J.F., Delehaunty, K.D., Fulton, L.A., Magrini, V.J., McGrath, S.D., Demeter, R.T., Vickery, T.L., Hundal, J., Cook, L.L., Swift, G.W., Reed, J.P., Alldredge, P.A., Wylie, T.N., Walker, J.R., Watson, M.A., Heath, S.E., Shannon, W.D., Varghese, N., Nagarajan, R., Payton, J.E., Baty, J.D., Kulkarni, S., Klco, J.M., Tomasson, M.H., Westervelt, P., Walter, M.J., Graubert, T.A., DiPersio, J.F., Ding, L., Mardis, E.R. & Wilson, R.K. (2012) The origin and evolution of mutations in acute myeloid leukemia. Cell, 150, 264278.
  • Zentz, E.L. (1990) Fibrocystic disease and breast cancer. Postgraduate Medicine, 87, 33.
  • Zhang, Y., Wong, J., Klinger, M., Tran, M.T., Shannon, K.M. & Killeen, N. (2009) MLL5 contributes to hematopoietic stem cell fitness and homeostasis. Blood, 113, 14551463.